Main > ONCOLOGY (**) > BTC>FGFR2+ > TREAT.: > USA. I. Pemigatinib Tablets
USA. I. Pemigatinib Tablets's subsections
(*) JP Approval Date: 2021. 03.23
Company
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site
USA. I. Pemigatinib Tablets's products
This section has no products